Use of anthraglucorhein in preparing medicine for treating ischemic cerebral vascular diseases
A technology for cerebrovascular disease and ischemia, applied in the field of application of chrysanthemum glycosides (elements) in the preparation of drugs for treating ischemic cerebrovascular disease, capable of solving problems that have not yet been reported
Patent Information
- Authority / Receiving Office
- CN · China
- Current Assignee / Owner
- Publication Date
- 2004-09-08
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
Technical field:
[0001] The invention relates to the use of rheum glycosides or rheum aglycones in the preparation of medicines for treating ischemic cerebrovascular diseases. Background technique:
[0002] Rhubarb is the root and rhizome of Rhubarb palmatum (Rheum.palmatam.L), Rhubarb tanguticum (R.tanguticumMacin.ex.Reg) and medicinal rhubarb (R.officinale.Baill) of Polygonaceae. Cold in nature and bitter in taste, it has the effects of purging heat and toxin, breaking stagnant stagnation, and promoting blood stasis. It is mostly used for constipation, delirium and madness, the onset of dysentery, vomiting of blood heat, amenorrhea due to blood stasis, etc. Modern pharmacological studies have shown that rhubarb has the effects of purging, antibacterial, anti-tumor, anti-hyperlipidemia, lowering blood pressure, invigorating the stomach, promoting gallbladder, protecting the liver, strengthening the heart, anti-inflammatory, delaying aging, and regulating immunity. one of ...
Examples
Embodiment
[0012] The experimental rats were grouped according to the random number table method, and were divided into model group and control group. The control group was: western medicine nimodipine control group; methyl ether, aloe-emodin, rhubarb dianthrone, palmate dianthrone) part of the control group.
[0013] The rheum glucoside powder was made into a suspension, and given to the test rats by gavage, once a day, the dose was 87.48mg·kg - d - ; Focal middle cerebral artery occlusion cerebral ischemia model was prepared by tying suture after intragastric administration for five days. After 4 hours, the morphological changes of the rats were observed, the neurological symptoms were scored, and then blood was taken from the abdominal aorta to prepare serum. Gained data compares with control group with SPSS10.0 statistical software processing, draws the following experimental results:
[0014] Compared with the control group, the neurosymptom score of the rhubarb part was signific...